intratumoral therapy
Recently Published Documents


TOTAL DOCUMENTS

24
(FIVE YEARS 0)

H-INDEX

8
(FIVE YEARS 0)

2020 ◽  
Vol 326 ◽  
pp. 203-221 ◽  
Author(s):  
Aric Huang ◽  
Melissa M. Pressnall ◽  
Ruolin Lu ◽  
Sebastian G. Huayamares ◽  
J. Daniel Griffin ◽  
...  


2020 ◽  
Author(s):  
Keyword(s):  


CNS Oncology ◽  
2019 ◽  
Vol 8 (3) ◽  
pp. CNS40 ◽  
Author(s):  
Joshua Loya ◽  
Charlie Zhang ◽  
Emily Cox ◽  
Achal S Achrol ◽  
Santosh Kesari

Management of high-grade gliomas (HGGs) remains a complex challenge with an overall poor prognosis despite aggressive multimodal treatment. New translational research has focused on maximizing tumor cell eradication through improved tumor cell targeting while minimizing collateral systemic side effects. In particular, biological intratumoral therapies have been the focus of novel translational research efforts due to their inherent potential to be both dynamically adaptive and target specific. This two part review will provide an overview of biological intratumoral therapies that have been evaluated in human clinical trials in HGGs, and summarize key advances and remaining challenges in the development of these therapies as a potential new paradigm in the management of HGGs. Part II discusses vector-based therapies, cell-based therapies and radioimmunotherapy.





2018 ◽  
Vol 07 (04) ◽  
Author(s):  
Max Cohen ◽  
Alfred Ketcham ◽  
Ronald Herberman




2015 ◽  
Vol 17 (suppl 5) ◽  
pp. v10.3-v10
Author(s):  
John Floyd ◽  
William Phillips ◽  
Beth Goins ◽  
Ande Bao ◽  
Andrew Brenner


2015 ◽  
Vol 125 (1) ◽  
pp. 1-7 ◽  
Author(s):  
Ankit I. Mehta ◽  
Andreas Linninger ◽  
Maciej S. Lesniak ◽  
Herbert H. Engelhard


2015 ◽  
Vol 06 (01) ◽  
pp. 001-010
Author(s):  
Benjamin Tharian ◽  
Nayana George ◽  
Ashley Canipe ◽  
Bronte Holt ◽  
Konrad Krall ◽  
...  

AbstractEver since the first endoscopic ultrasound-guided fine needle aspiration (FNA) was done in 1992, the procedure has evolved to become an indispensable tool for tissue acquisition in patients with gastrointestinal tumors and periluminal lesions. With the growing evidence of neoadjuvant therapy and research into intratumoral therapy, the need to obtain tissue diagnosis for tumors is quite apparent. This review provides an overall perspective to the endosonographer on various issues that are a key for best practices in FNA, in addition to being an update for practicing experienced endosonographers.



Sign in / Sign up

Export Citation Format

Share Document